Olive Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 58.95 Cr
as on 02-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 02-07-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 47.50 Cr
as on 02-07-2024
- Satisfied Charges ₹ 63.51 Cr
as on 02-07-2024
- Revenue 30.29%
(FY 2020)
- Profit 212.46%
(FY 2020)
- Ebitda -29.68%
(FY 2020)
- Net Worth 106.94%
(FY 2020)
- Total Assets -2.55%
(FY 2020)
About Olive Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 58.95 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹47.50 Cr. The company has closed loans amounting to ₹63.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prasad Padmanabhan, Joseph Molath, and Juie Hilal serve as directors at the Company.
- CIN/LLPIN
U24230KA2007PTC043892
- Company No.
043892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore Rural, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Olive Lifesciences Private Limited offer?
Olive Lifesciences Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Ayurvedic & Herbal Extracts, Fruit Extracts, Plant Extracts, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Olive Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Joseph Molath  | Managing Director | 17-Jul-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prasad Padmanabhan | Whole-Time Director | 17-Jul-2019 | Current |
| Juie Hilal | Director | 18-Sep-2007 | Current |
Financial Performance and Corporate Structure Insights of Olive Lifesciences.
Olive Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 30.29% increase. The company also saw a substantial improvement in profitability, with a 212.46% increase in profit. The company's net worth Soared by an impressive increase of 106.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Olive Lifesciences?
In 2021, Olive Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Mar 2015 | ₹10.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Mar 2014 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 02 Jan 2014 | ₹15.00 Cr | Open |
How Many Employees Work at Olive Lifesciences?
Olive Lifesciences has a workforce of 58 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Olive Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olive Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
